1. Introducing Perspectives on Comparative Effectiveness Research

   • Howard G. Birnbaum
   • Paul E. Greenberg

   Editorial 18 October 2012 Pages: 787 - 788

2. Perspectives on Comparative Effectiveness Research

   • Dave Nellesen
   • Howard G. Birnbaum
   • Paul E. Greenberg

   Editorial 18 October 2012 Pages: 789 - 798

   

3. Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS

   • Kalipso Chalkidou
   • Tom Walley

   International Perspectives 18 October 2012 Pages: 799 - 811

   

4. International Comparison of Comparative Effectiveness Research in Five Jurisdictions

   • Adrian R. Levy
   • Craig Mitton
   • Andrew H. Briggs

   International Perspectives 18 October 2012 Pages: 813 - 830

   

5. Value-Based Approaches to Healthcare Systems and Pharmacoeconomics Requirements in Asia

   • Isao Kamae

   International Perspectives 18 October 2012 Pages: 831 - 838

   

6. Guiding Comparative Effectiveness Research–A US Perspective

   International Perspectives 18 October 2012 Pages: 839 - 842

7. The Economics of Comparative Effectiveness Studies

   • David Meltzer
   • Anirban Basu
   • Rena Conti

   Policy and Implementation 18 October 2012 Pages: 843 - 853

   

8. Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research

   • Louis P. Garrison Jr

   Policy and Implementation 18 October 2012 Pages: 855 - 865

   

9. Cost-Effectiveness Analysis in Markets with High Fixed Costs

   • David M. Cutler
   • Keith M. Marzilli Ericson

   Policy and Implementation 18 October 2012 Pages: 867 - 875

   

10. Comparative Effectiveness Regulations and Pharmaceutical Innovation

    • John A. Vernon
    • Joseph H. Golec
    • J. Stedman Stevens

    Policy and Implementation 18 October 2012 Pages: 877 - 887

    

11. Perspective and Desire in Comparative Effectiveness Research

    • Anthony J. Culyer

    Policy and Implementation 18 October 2012 Pages: 889 - 897

12. Comparative Effectiveness Research and the Psychology of Medical Practice

    • Jerome P. Kassirer
    • John B. Wong

    Policy and Implementation 18 October 2012 Pages: 899 - 903

13. Comparative Effectiveness Research and Personalized Medicine

    • Robert S. Epstein
    • J. Russell Teagarden

    Industry Perspectives 18 October 2012 Pages: 905 - 913

    

14. Comparative Effectiveness Research

    • Marc L. Berger
    • David Grainger

    Industry Perspectives 18 October 2012 Pages: 915 - 922

15. Comparative Effectiveness, Personalized Medicine and Innovation

    • Adrian Thomas
    • Audrey Phillips
    • Catherine Tak Piech

    Industry Perspectives 18 October 2012 Pages: 923 - 930

16. Managed Care Pharmacy Sees Potential of Comparative Effectiveness Research to Improve Patient Care and Lower Costs

    • Judith Cahill
    • Neal Learner

    Industry Perspectives 18 October 2012 Pages: 931 - 934

17. Comparative Effectiveness Without Head-to-Head Trials

    • James E. Signorovitch
    • Eric Q. Wu
    • Parvez M. Mulani

    Methodological Considerations 18 October 2012 Pages: 935 - 945

    

18. There’s a Reason They Call Them Dummy Variables

    • William H. Crown

    Methodological Considerations 18 October 2012 Pages: 947 - 955

    

19. No Head-to-Head Trial? Simulate the Missing Arms

    • J.Jaime Caro
    • K. Jack Ishak

    Methodological Considerations 18 October 2012 Pages: 957 - 967

    

20. Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials

    • C. Daniel Mullins
    • Danielle Whicher
    • Sean Tunis

    Methodological Considerations 18 October 2012 Pages: 969 - 976